TITLE

COMMENTARY: Review: Magnesium is effective and safe for acute management of rapid atrial fibrillation

AUTHOR(S)
Dunn, Andrew
PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects upon the findings of a study, that investigated the use of magnesium for acute management of rapid atrial fibrillation (AF). He criticizes the comparison between magnesium and placebo, that was included in the study. He also comments on the study's conclusion that magnesium is less effective than calcium-channel blockers for rate control, but more effective for rhythm control and suggests further study in a large randomized trial.
ACCESSION #
28019862

 

Related Articles

  • Review: Magnesium is effective and safe for acute management of rapid atrial fibrillation.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p61 

    The article offers information on a study, that investigated the use of magnesium for acute management of rapid atrial fibrillation (AF). It describes the procedure and randomized controlled trials (RCTs), that were carried out during the study. The study reveals that magnesium was more...

  • Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis. Ho, Kwok M.; Sheridan, David J.; Paterson, Timothy // Heart;Nov2007, Vol. 93 Issue 11, p1433 

    Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial fibrillation to sinus rhythm, reducing ventricular response and risk of bradycardia. Design and data sources: Randomised controlled trials evaluating intravenous magnesium to treat acute onset atrial...

  • In patients with atrial fibrillation, adding clopidogrel to aspirin reduced major vascular events but increased bleeding. Cairns, John A; Connolly, S. J. // ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p6 

    The article presents the findings of a study to assess whether adding clopidogrel to aspirin reduces risk for vascular events in patients with atrial fibrillation (AF) who are unsuitable for vitamin K antagonist therapy. The research method included randomized placebo controlled trials. The...

  • Perioperative Bridging Anticoagulation Unhelpful for Invasive Procedures. EBELL, MARK H. // American Family Physician;1/15/2016, Vol. 93 Issue 2, p130 

    The article examines whether bridging anticoagulation during invasive procedures improve outcomes in patients with atrial fibrillation who take warfarin, or Coumadin. Topics discussed include warfarin obtained by participants for three months, absence of anticoagulation in the placebo group for...

  • A randomized trial of budiodarone in paroxysmal atrial fibrillation. Ezekowitz, Michael; Nagarakanti, Rangadham; Lubinski, Andrzej; Bandman, Olga; Canafax, Daniel; Ellis, David; Milner, Peter; Ziola, Margaret; Thibault, Bernard; Hohnloser, Stefan // Journal of Interventional Cardiac Electrophysiology;Jun2012, Vol. 34 Issue 1, p1 

    Objective: The aim of this study was to investigate the preliminary safety and efficacy of three doses of budiodarone in patients with paroxysmal atrial fibrillation. Background: Budiodarone is a chemical analogue of amiodarone and shares its mixed ion channel electrophysiological properties. It...

  • Another Warfarin Replacement on Horizon. Elliott, William T. // Neurology Alert;Jan2011 Phamacology Watch, p1 

    The article discusses the Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared With Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF) study which revealed the efficacy of rivaroxaban as another warfarin replacement for preventing stroke and blood...

  • Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation. Rillig, Andreas; Lin, Tina; Ouyang, Feifan; Kuck, Karl-Heinz; Tilz, Roland Richard // JAFIB: Journal of Atrial Fibrillation; 

    In the past years, catheter ablation has evolved into an effective treatment option for symptomatic, drug-resistant atrial fibrillation (AF) and it has recently been implemented as a primary treatment strategy for patients with paroxysmal AF. Although a significant number of studies have...

  • Cost-Effectiveness of Atrial Fibrillation Ablation. Kudaiberdieva, Gulmira; Gorenek, Bulent // JAFIB: Journal of Atrial Fibrillation; 

    Atrial fibrillation (AF) is a frequently encountered rhythm disorder, characterized by high recurrence rate, frequent hospitalizations, reduced quality-of-life and increased the risk of mortality, heart failure and stroke. Along with these clinical complications this type of arrhythmia is the...

  • Newer oral anticoagulants superior to warfarin in atrial fibrillation. Ray, Sarah // Pharmacy Today;May2014, Vol. 20 Issue 5, p20 

    The article discusses the study on three newer oral anticoagulants to prevent stroke in atrial fibrillation patients. It details how the study was conducted which involved a meta-analysis of four Phase III randomized controlled trials to compare the effectiveness and safety of the anticoagulants...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics